Therapies

Biopharmaceutical company AbbVie and Belgium medical technology manufacturer iSTAR Medical have announced a strategic alliance to further develop and commercialise...

The MIGS devices market in Australia is set to be the fastest-growing in the Asia-Pacific (APAC) region, buoyed by the...

New six-year data for a defocus lens by Hoya marks the longest study of a myopia control spectacle lens –...

RANZCO has published a new position paper on myopia, advocating for a more nuanced public health policy that incorporates increased...

Pharmacists are being called upon to help the millions of Australians suffering dry eye disease in the wake of new...

Research estimates myopia will affect 50% of the world by 2050, and recent COVID lockdowns appear to have only worsened...

The suppliers of two new anti-VEGF therapies recently cleared in the US that work to reduce macular disease treatment burdens...

  At the completion of this CPD activity, optometrists will have developed their knowledge of treatment options for severe dry...

Spectacles that use SightGlass Vision’s trademarked Diffusion Optics Technology have demonstrated efficacy in slowing the progression of myopia in children,...

Half a decade of data on the second generation iStent inject has shown a significant reduction in intraocular pressure (IOP)...